HomeNewsBusinessEconomyGST Council Meeting: Major tax breaks with 'zero rating' of COVID essentials feasible, experts say

GST Council Meeting: Major tax breaks with 'zero rating' of COVID essentials feasible, experts say

43rd GST Council Meeting: GST Council’s meeting on May 28 can consider total tax exemption for medical supplies needed for combating COVID-19, and may also discuss tax tweaks to help sectors that have been hit hard by the second wave as well as compensation for states, experts say.

May 28, 2021 / 09:05 IST
Story continues below Advertisement
File image of Finance Minister Nirmala Sitharaman and Minister of State for Finance Anurag Thakur at GST Council Meeting (Image: Finance Ministry Twitter handle)
File image of Finance Minister Nirmala Sitharaman and Minister of State for Finance Anurag Thakur at GST Council Meeting (Image: Finance Ministry Twitter handle)

The Goods and Service Tax Council can consider ‘zero rating’, or complete tax exemption, to products crucially needed in the fight against COVID-19, in its next meeting on May 28, experts and analysts said.

The proposal was first publicly mooted by Bharatiya Janata Party’s Rajya Sabha member and former Bihar Deputy Chief Minister Sushil Kumar Modi in an article in the Economic Times on May 25.

Story continues below Advertisement

“Not only would the products be exempted from tax, but the tax paid on the purchase of inputs required for the manufacture of such products would also be refunded to the manufacturer. Zero-rating would, thus, remove all taxes on these products and will help lower prices,” the BJP leader said.

The GST Council meeting comes at a time when many states are forcefully demanding that taxes should be removed or reduced for oxygen cylinders, ventilators, concentrators, and life-saving drugs like Remdesivir, which many COVID-19 patients need.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show